| Literature DB >> 19355907 |
Elaine V Lourenço1, Antonio La Cava.
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies that can form immune complexes and deposit in tissues, causing inflammation and organ damage. There is evidence that interferons and some interleukins can have an active role in the pathogenesis of SLE and can contribute significantly to the immune imbalance in the disease, whereas the role of some cytokines (such as TNF) is still debated. This review discusses the activity of several cytokines in SLE, their effects on the immune cells in relation to the disease pathogenesis, and the promise and limitations of cytokine-based therapies in clinical trials for lupus patients.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19355907 PMCID: PMC3589140 DOI: 10.2174/156652409787847263
Source DB: PubMed Journal: Curr Mol Med ISSN: 1566-5240 Impact factor: 2.222